Globally leading research into neurological diseases
Neurological conditions – such as Alzheimer’s, Huntington’s, Parkinson’s, multiple sclerosis, stroke and acquired brain injury – are the leading cause of death and disability globally. These conditions have a devastating impact on the lives of millions of people around the world, as well as on their families and loved ones.
UCL has worked at the frontiers of brain science for more than three decades, nurturing one of the largest groups of neuroscience experts in the world. It has been painstaking, slow, and at times disheartening work. But thanks to the sustained efforts of our extraordinary community and the partners who have joined us along the way, and technological leaps forward, there is hope.
Join us as we find cures for some of the most intractable diseases affecting humanity today
““This is the beginning of the end for dementia. We have no other choice: we can, will and must find treatments. We will look back at today and see this as the start of a change.” - Professor Nick Fox, Co-Chair of the Leonard Wolfson Experimental Neurology Centre, Director of the UCL Dementia Research Centre
“The chance to be a part of the larger fight for better treatment and a cure has helped me fight my own battle. The power of this experience comes from both the cause and the support I received from the team. The clinical and support team here are exceptionally knowledgeable, accessible, competent and caring. I am deeply grateful for the opportunity to participate in the cutting edge research being done at the centre.” - Elizabeth, an experimental trial patient at the Leonard Wolfson Experimental Neurology Centre living with Parkinson’s disease
A new home for 21st-century neuroscience
To truly transform the landscape for patients, we need to transform how we work. We are planning a new facility at the core of London’s unique health ecosystem. This will give us the best environment to support research at the scale and pace we need to find cures for this urgent global health challenge.
Built to translate fundamental research into cures, faster and at scale, our new centre will bring clinicians, researchers, industry partners and patients together under one roof in one of the world's most exciting research environments, underpinned by visionary philanthropy.
Inside the flagship centre
- Over 500 researchers from a range of disciplines working across six floors
- Cutting-edge research labs, teaching facilities and collaborative workspaces
- A new headquarters for the UK Dementia Research Institute and its largest research group
- Specialised patient care and clinical services
- Outpatient facilities and public spaces that put patients at ease
Our donor community
UCL’s Professor Sir John Hardy was the first to identify the role of amyloid in Alzheimer’s disease - now, three decades later, that finding has resulted in a drug that may help patients.